
Panakes Partners-led syndicate invests EUR20 million in InnovHeart
InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has received EUR20 million in a round of equity financing from a syndicate of investors. The Series B round was raised from existing Milan-based investor Genextra which has been the sole investor since
